Sato C, Kitajima K, Inoue S, Seki T, Troy F A, Inoue Y
Department of Biophysics and Biochemistry, Graduate School of Science, University of Tokyo, Japan.
J Biol Chem. 1995 Aug 11;270(32):18923-8. doi: 10.1074/jbc.270.32.18923.
A rapid, sensitive, and facile method for screening and characterizing anti-polysialic acid (polySia) antibodies using lipid-conjugated oligo/polysialic acids (oligo/polySia) was developed, which is based on an enzyme-linked immunosorbent assay. Homooligo/polymers of alpha 2-->8-linked N-acetylneuraminic acid (Neu5Ac), N-glycoly-neuraminic acid, and 2-keto-3-deoxy-D-galacto-nononic acid (KDN) were conjugated with phosphatidylethanolamine dipalmitoyl (PE) by reductive amination to prepare neo-oligo/polysialoglycolipids (oligo/polySia-PE). Using this method, the anti-polySia equine antibody, H.46, bound to (-->8Neu5Ac alpha 2-->)n-PE, where n = 9 or more residues, a result in confirmation of previous binding studies using radiolabeled oligo/polyNeu5Ac. The antigenic specificity and sensitivity of two monoclonal anti-poly/oligoNeu5Ac antibodies (mAb.12E3 and mAb.5A5) and one anti-oligoKDN antibody (mAb.kdn8kdn), were also determined. mAb.12E3 could detect as little as 25 pg/well of oligo/polyNeu5Ac-PE, while 0.4 ng/well of oligo/polyNeu5Ac-PE to be detected. mAb.kdn8kdn detected as little as 12 ng/well of oligoKDN-PE. Using a series of oligo/polySia-PE with defined degrees of polymerization (DP), the minimum chain length for immunoreactivity of the anti-polySia antibodies was determined to be: DP 5 for mAb.12E3; DP 3 for mAb.5A5; DP 2 for mAb.kdn8kdn; and DP 8 for H.46. Thus, mAb.12E3 and mAb.5A5 recognize shorter oligomers of Neu5Ac than H.46, a finding that is of practical value for identifying shorter oligoSia chains in glycoconjugates. Because mAb.12E3 and mAb.5A5 also recognize extended polySia chains, these antibodies cannot be used, however, to differentiate between short and long chains of polySia when both are expressed on the same molecule.
开发了一种基于酶联免疫吸附测定的快速、灵敏且简便的方法,用于使用脂质共轭寡聚/多聚唾液酸(oligo/polySia)筛选和鉴定抗多聚唾液酸(polySia)抗体。通过还原胺化将α2→8连接的N-乙酰神经氨酸(Neu5Ac)、N-糖基神经氨酸和2-酮-3-脱氧-D-半乳糖壬酸(KDN)的同型寡聚物/聚合物与二棕榈酰磷脂酰乙醇胺(PE)共轭,以制备新的寡聚/多聚唾液酸糖脂(oligo/polySia-PE)。使用该方法,抗多聚唾液酸马抗体H.46与(→8Neu5Acα2→)n-PE结合,其中n = 9个或更多残基,这一结果证实了先前使用放射性标记的寡聚/多聚Neu5Ac进行的结合研究。还测定了两种抗多聚/寡聚Neu5Ac单克隆抗体(mAb.12E3和mAb.5A5)和一种抗寡聚KDN抗体(mAb.kdn8kdn)的抗原特异性和敏感性。mAb.12E3能够检测低至25 pg/孔的寡聚/多聚Neu5Ac-PE,而mAb.5A5检测的寡聚/多聚Neu5Ac-PE低至0.4 ng/孔。mAb.kdn8kdn检测低至12 ng/孔的寡聚KDN-PE。使用一系列具有确定聚合度(DP)的寡聚/多聚Sia-PE,确定抗多聚唾液酸抗体免疫反应性的最小链长度为:mAb.12E3为DP 5;mAb.5A5为DP 3;mAb.kdn8kdn为DP 2;H.46为DP 8。因此,mAb.12E3和mAb.5A5识别的Neu5Ac寡聚物比H.46短,这一发现对于鉴定糖缀合物中较短的寡聚唾液酸链具有实际价值。然而,由于mAb.12E3和mAb.5A5也识别延伸的多聚唾液酸链,当两者在同一分子上表达时,这些抗体不能用于区分多聚唾液酸的短链和长链。